/
HIV Enrollment Form✅
  • Ready for review
  • HIV Enrollment Form✅

    Questions

    Concepts

    Questions

    Concepts

    What do you want to do?

    🔘 Enrol a new client

    🔘 Transfer in a client

    🔘 Enrol a Mother into PMTCT program

    🔘 Re-enrol a client

    166937 Care management plan

    Enrolment Date

    ␣␣-␣␣-␣␣␣␣ 📆

    160555 Date enrolled in HIV care

    Unique ID

    __________________________________

    162576 New patient identifier

    Other Unique ID

    __________________________________

    162727 Other facility patient identifier

    Entry Point

    🔽 Voluntary male circumcision clinic

    🔽 Private home-based care

    🔽 Adolescent outreach program

    🔽 Private Company

    🔽 Outreach program

    🔽 Community-based organization

    🔽 Outpatient department

    🔽 Pediatric inpatient service

    🔽 Voluntary counseling and testing program

    🔽 Maternal and child health program

    🔽 Vaccination service

    🔽 Nutrition program

    🔽 Sex worker outreach program

    🔽 Intravenous venous drug user outreach program

    🔽 Sexually transmitted infection program/clinic

    🔽 Under five clinic

    🔽 Tuberculosis treatment program

    🔽 Adult inpatient service

    160540 Method of enrollment

    Entry Point - Other

    __________________________________

    61011 Free text comment

    Population Category

    🔘 General population

    🔘 Key population

    🔘 Priority population

    166432 Study population type

    Key Population Type

    🔘 Intravenous drug user

    🔘 Male who has sex with men

    🔘 Prisoners

    🔘 Sex worker

    🔘 Transgender Persons

    166433 Target population type

    Priority Population Type

    🔽 Adolescent Girls & Young Women

    🔽 Client of sex worker

    🔽 Fisher Folk

    🔽 Long-distance truck driver

    🔽 Migrant Workers

    🔽 Non-intravenous drug user

    🔽 Refugee

    🔽 Uniformed Forces

    🔽 Other

    166433 Target population type

     

    Transfer-In

    Transferring Facility

    __________________________________

    160535 Transferred from location

    Start ART Date

    ␣␣-␣␣-␣␣␣␣ 📆

    159599 Antiretroviral treatment start date

    Regimen

    🔽 ABC + 3TC + DTG
    🔽 ABC + 3TC + EFV
    🔽 ABC + 3TC + LPV/r
    🔽 ABC + 3TC + NVP
    🔽 AZT + 3TC + ATV/r
    🔽 AZT + 3TC + DTG
    🔽 AZT + 3TC + EFV
    🔽 AZT + 3TC + LPV/r
    🔽 AZT + 3TC + NVP
    🔽 DRV/r + DTG + ABC + 3TC
    🔽 DRV/r + DTG + AZT + 3TC
    🔽 DRV/r + DTG + TDF + 3TC
    🔽 DRV/r + RAL + AZT + 3TC
    🔽 DRV/r + RAL + ABC + 3TC
    🔽 DRV/r + RAL + TDF + 3TC
    🔽 TDF + 3TC + ATV/r
    🔽 TDF + 3TC + DTG
    🔽 TDF + 3TC + EFV
    🔽 TDF + 3TC + LPV/r
    🔽 TDF + 3TC + NVP

    164432 ARV regimen/code for drugs collected

    Date of Enrolment into HIV Care

    ␣␣-␣␣-␣␣␣␣ 📆

    163260 Date of first visit

    HIV Diagnosis

    Date Confirmed HIV Positive

    ␣␣-␣␣-␣␣␣␣ 📆

    160554 Date of HIV diagnosis

    Test Type

    🔘 Rapid test for HIV

    🔘 HIV DNA polymerase chain reaction

    🔘 Unknown

    164401 HIV test performed

    Previous ARV/HAART Use

     

    Indication/intent of therapy

    ☑️ Pre Exposure Prophylaxis (PrEP)

    ☑️ Prevention of Mother to Child Transmission (PMTCT)

    ☑️ Post-exposure prophylaxis (PEP)

    160846 Indication/intent of therapy

    Use of Pre Exposure Prophylaxis (PrEP)
    🔘 Yes
    🔘 No
    🔘 Unknown

    166655 Pre-exposure prophylaxis (PrEP) regimen
    1065 Yes

    1066 No

    1067 Unknown

    Use of Post-exposure prophylaxis (PEP)***CC
    🔘 Yes
    🔘 No
    🔘 Unknown

    164845 Eligible for post-exposure prophylaxis
    1065 Yes

    1066 No

    1067 Unknown

    ART Use for Prevention of Mother to Child Transmission of HIV***CC
    🔘 Yes
    🔘 No
    🔘 Unknown

    163532 Mother enrolled in prevention of maternal to child transmission (PMTCT) program
    1065 Yes

    1066 No

    1067 Unknown

    Nucleoside Reverse Transcriptase Inhibitors (NRTIS)***CC
    ☑️ Zidovudine
    ☑️ Tenofovir
    ☑️ Lamivudine
    ☑️ Emtricitabine
    ☑️ Abacavir
    ☑️ Other antiretroviral drug

    NRTIS Nucleoside Reverse Transcriptase Inhibitors (NRTIS) ARVs
    86663 Zidovudine

    84796 Tenofovir disoproxil

    78643 Lamivudine

    75628 Emtricitabine

    70056 Abacavir

    5424 Other antiretroviral drug

    Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIS)***CC
    ☑️ Etravirine
    ☑️ Nevirapine
    ☑️ Efavirenz
    ☑️ Other antiretroviral drug
    ☑️ Unknown

    NNRTIS Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIS) ARVs
    159810 Etravirine

    80586 Nevirapine

    75523 Efavirenz

    5424 Other antiretroviral drug

    1067 Unknown

    Protease Inhibitors (PIS)***CC
    ☑️ Tipranavir
    ☑️ Saquinavir
    ☑️ Ritonavir
    ☑️ Fosamprenavir
    ☑️ Darunavir
    ☑️ Atazanavir

    ProteaseInhibitorsProtease Inhibitors (PIS) ARVs
    85160 Tipranavir

    83690 Saquinavir

    83412 Ritonavir

    76658 Fosamprenavir

    74258 Darunavir

    71647 Atazanavir

    Other HIV Drug Classes
    ☑️ Raltegravir
    ☑️ Dolutegravir
    ☑️ Maraviroc
    ☑️ Enfuvirtide
    ☑️ Other antiretroviral drug
    ☑️ Unknown

    1193 Current drugs used
    154378 Raltegravir

    165085 Dolutegravir

    154376 Maraviroc

    75676 Enfuvirtide

    5424 Other antiretroviral drug

    1067 Unknown

    Treatment Supporter

     

    Treatment Supporter Name

    __________________________________

    160638 Name of treatment supporter

    Treatment Supporter Phone Number

    __________________________________

    160642 Telephone number of treatment supporter

    Treatment Supporter Relationship

    🔽 Sibling

    🔽 Parent

    🔽 Partner or spouse

    🔽 Guardian

    🔽 Grandparent

    🔽 Other

    160640 Treatment supporter relationship to patient

    Re-enrollment

     

    Date of Re-enrollment

    ␣␣-␣␣-␣␣␣␣ 📆

    160753 Date of event

    Reason For Re-enrolment

    __________________________________

    160632 Free text general

    Related pages